rs11627387

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_005956.4(MTHFD1):​c.2719-955G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.275 in 151,962 control chromosomes in the GnomAD database, including 5,918 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.28 ( 5918 hom., cov: 32)

Consequence

MTHFD1
NM_005956.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.113

Publications

28 publications found
Variant links:
Genes affected
MTHFD1 (HGNC:7432): (methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1) This gene encodes a protein that possesses three distinct enzymatic activities, 5,10-methylenetetrahydrofolate dehydrogenase, 5,10-methenyltetrahydrofolate cyclohydrolase and 10-formyltetrahydrofolate synthetase. Each of these activities catalyzes one of three sequential reactions in the interconversion of 1-carbon derivatives of tetrahydrofolate, which are substrates for methionine, thymidylate, and de novo purine syntheses. The trifunctional enzymatic activities are conferred by two major domains, an aminoterminal portion containing the dehydrogenase and cyclohydrolase activities and a larger synthetase domain. [provided by RefSeq, Jul 2008]
ZBTB25 (HGNC:13112): (zinc finger and BTB domain containing 25) Predicted to enable DNA-binding transcription repressor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.407 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005956.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MTHFD1
NM_005956.4
MANE Select
c.2719-955G>A
intron
N/ANP_005947.3
MTHFD1
NM_001364837.1
c.2718+2384G>A
intron
N/ANP_001351766.1F5H2F4
ZBTB25
NM_001304508.1
c.174-7621C>T
intron
N/ANP_001291437.1G3V2K3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MTHFD1
ENST00000652337.1
MANE Select
c.2719-955G>A
intron
N/AENSP00000498336.1P11586
ZBTB25
ENST00000555220.5
TSL:1
c.174-7621C>T
intron
N/AENSP00000450718.1G3V2K3
MTHFD1
ENST00000545908.6
TSL:2
c.2718+2384G>A
intron
N/AENSP00000438588.2F5H2F4

Frequencies

GnomAD3 genomes
AF:
0.276
AC:
41846
AN:
151844
Hom.:
5920
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.218
Gnomad AMI
AF:
0.214
Gnomad AMR
AF:
0.221
Gnomad ASJ
AF:
0.297
Gnomad EAS
AF:
0.422
Gnomad SAS
AF:
0.253
Gnomad FIN
AF:
0.306
Gnomad MID
AF:
0.241
Gnomad NFE
AF:
0.308
Gnomad OTH
AF:
0.281
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.275
AC:
41859
AN:
151962
Hom.:
5918
Cov.:
32
AF XY:
0.277
AC XY:
20568
AN XY:
74252
show subpopulations
African (AFR)
AF:
0.218
AC:
9025
AN:
41436
American (AMR)
AF:
0.221
AC:
3371
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.297
AC:
1031
AN:
3470
East Asian (EAS)
AF:
0.422
AC:
2170
AN:
5142
South Asian (SAS)
AF:
0.254
AC:
1229
AN:
4830
European-Finnish (FIN)
AF:
0.306
AC:
3228
AN:
10536
Middle Eastern (MID)
AF:
0.231
AC:
68
AN:
294
European-Non Finnish (NFE)
AF:
0.308
AC:
20946
AN:
67952
Other (OTH)
AF:
0.282
AC:
596
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1534
3068
4603
6137
7671
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
444
888
1332
1776
2220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.290
Hom.:
8459
Bravo
AF:
0.265
Asia WGS
AF:
0.329
AC:
1144
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.65
DANN
Benign
0.63
PhyloP100
-0.11
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11627387; hg19: chr14-64923977; API